Institute of Immunology

Director:

  • Prof. Dr. Alexander Scheffold
     

The Institute of Immunology is actively involved in biomedical research and teaching. Immunology is a central cross-sectional discipline in medicine and many innovative therapies modulate the immune system. The Institute of Immunology forms an important interdisciplinary link between basic biomedical research and applied clinical research.
The research groups investigate the cellular players and molecular mechanisms of allergies, chronic inflammatory bowel diseases, autoimmunity and tumor immunology. The focus is on the functional analysis of human immune cells, in particular the characterization of T cells that direct protective or pathological immune reactions, the pathways of signal transduction in T cells, and the molecular control of cell death.
The institute provides central platforms for flow-cytometry and cell sorting as well as for proteome analysis using differential 2D gel electrophoresis. Scientists of the Institute are integral part of regional and national networks, e.g. in the Cluster of Excellence "Inflammation at Interfaces", SFB 877: Proteolysis as a Regulatory Event in Pathophysiology, TRR241: Immune-Epithelial Communication in Inflammatory Bowel Diseases, and DFG Research Group FOR2799: Receiving and Translating Signals via the γδ T Cell Receptor, as well as the Kiel Oncology Network (KON) and the priority research area "Kiel Life Science" (KLS).